BeOne Medicines (ONC) FCF Margin Growth (3y) (2018 - 2026)
BeOne Medicines (ONC) FCF Margin Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15,064.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 6,066.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,064.00 |
| Dec 31, 2025 | 14,958.00 |
| Sep 30, 2025 | 20,757.00 |
| Jun 30, 2025 | 13,219.00 |
| Mar 31, 2025 | 9,044.00 |
| Dec 31, 2024 | -4,701.00 |
| Sep 30, 2024 | 24,405.00 |
| Jun 30, 2024 | 30,766.00 |
| Mar 31, 2024 | -7,743.00 |
| Dec 31, 2023 | 33,421.00 |
| Sep 30, 2023 | 41,949.00 |
| Jun 30, 2023 | 36,273.00 |
| Mar 31, 2023 | 56,738.00 |
| Dec 31, 2022 | 46,008.00 |
| Sep 30, 2022 | 38,388.00 |
| Jun 30, 2022 | -10,100.00 |
| Mar 31, 2022 | 15,713.00 |
| Dec 31, 2021 | 42,423.00 |
| Sep 30, 2021 | 7,195.00 |
| Jun 30, 2021 | -5,718.00 |